Background and aims High lipoprotein (a)[Lp (a)] concentrations are associated with
increased coronary artery disease (CAD) risk. Lp (a) is regulated mainly genetically by the …

Abstract Background/Aims: Lp (a) levels have long been recognized as a potential risk factor
for coronary heart disease that is almost completely under genetic control. Much of the …

Increasing evidence has implicated lipoprotein (a)[Lp (a)] in the causality of atherosclerosis
and calcific aortic stenosis. This has stimulated immense interest in developing novel …

Background Understanding the genetic contribution to phenotype variation of human groups
is necessary to elucidate differences in disease predisposition and response to …

Although numerous studies since the 1960s have identified increased plasma
concentrations of lipoprotein (a)[Lp (a)] as a risk factor for coronary heart disease (CHD), the …

Lipoprotein Lp (a) levels are highly heritable and are associated with cardiovascular risk.
We performed a genome-wide linkage analysis to delineate the genomic regions that …

Lipoprotein (a), abbreviated Lp (a), is accepted as a potential selective or additional risk
factor for premature atherosclerosis. Though it may be considered to be closely related to …

Two enhancer regions upstream of the apolipoprotein (a)(apo (a)) gene were amplified and
sequenced from subjects who were known to express abnormally high or low amounts of …

The techniques of haemapheresis originated in the development of centrifugal devices
separating cells from plasma and later on plasma from cells. Subsequently membrane …

Apolipoprotein [a](apo [a]) gene size is a major predictor of lipoprotein [a] level. To
determine genetic predictors of allele-specific apo [a] levels beyond gene size, we evaluated …